Chronic Kidney Disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients of both sexes; over the age of 19; diagnosis of chronic kidney disease and who have been on a regular hemodialysis program for at least 3 months, since this is the time used to confirm the chronicity of renal disease
Exclusion criteria
Exclusion criteria: Patients with a history of hypersensitivity to resveratrol will be excluded from the study; patients with food allergy containing resveratrol;cancer patients; with acute renal failure; in use of anti-inflammatory drugs; use of omega 3 supplementation; bedridden patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1: Reduction of serological inflammatory markers, verified by turbidimetry methods and enzyme-linked immunosorbent assay (ELISA), of at least 10%. Data collected before the intervention and 30 days after the intervention. ;Expected outcome 2: Reduction of serological oxidative stress markers, measured by spectrophotometry, of at least 10%. Data collected before the intervention and 30 days after the intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome 1: Improvement of the quality of life, evaluated by the questionnaire "quality of life for chronic kidney disease", of at least 20%. Data collected before the intervention and 30 days after the intervention. | — |
Countries
Brazil
Contacts
Universidade do Sul de Santa Catarina